XBKK
THREL
Market cap21mUSD
Nov 12, Last price
1.14THB
Name
Thaire Life Assurance PCL
Chart & performance
P/E
—
P/S
0.27
EPS
—
Div yield, %
6.24%
Shrs. gr., 5y
0.33%
Rev. gr., 5y
2.20%
Revenues
2.60b
-42.60%
Net income
-77m
L-9.52%
CFO
5m
-90.88%
Dividend
May 03, 20240.07 THB/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Thaire Life Assurance Public Company Limited is a specialist provider of life reinsurance solutions, serving a variety of life insurance carriers throughout Thailand. Its business operations are structured into two distinct divisions: conventional and non-conventional product offerings. Beyond its core reinsurance activities, the company also delivers a comprehensive suite of services, including market research and analytical insights, strategic marketing planning, product innovation and development, creation of new distribution channels, expert medical underwriting consultation, and efficient claims administration. The firm was established in 2000 and maintains its headquarters in Bangkok, Thailand.
Key people
Oran Vongsuraphichet
Vice Chairman of the Board · since 2022
Sirin Dhumma-Upakorn
Chief Financial Officer, Senior Vice President - Accounting, Finance, Financial Planning & Analysis and Enterprise Risk Management, Company Secretary · since 2023
Navadee Ruangrattanametee
Senior Vice President - Business Development 1 · since 2023
Pakamol Surakulkawin
Senior Vice President - Investment · since 2023
Nutchakorn Suwansathit
Senior Vice President - Business Development 2 · since 2023
Vipon Vorasowharid
Managing Director, Executive Director · since 2023
Sutti Rajitrangson
Director · since 2024
Independent Director · since 2016
Independent Director · since 2019
Nophadon Ruengchindato
Independent Director · since 2023
Independent Director · since 2016
Kittiya Todhanakasem
Independent Director · since 2021
Independent Director · since 2025
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||